Ascribe Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $15M

  • Investors
  • 14

Ascribe General Information

Description

Developer of crop protection products designed to protect crops from pests, fungi and other small orgasms. The company's products are developed by researching the interaction of microbes and plants at the molecular level to identify the signaling molecules that activate a plant's natural immunity, enabling farmers to enhance the quality and productivity of crops.

Contact Information

Website
www.ascribebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 95 Brown Road
  • Suite 202
  • Ithaca, NY 14850
  • United States
+1 (607)
Primary Industry
Agricultural Chemicals
Other Industries
Biotechnology
Vertical(s)
CleanTech, LOHAS & Wellness, AgTech, Life Sciences
Corporate Office
  • 95 Brown Road
  • Suite 202
  • Ithaca, NY 14850
  • United States
+1 (607)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascribe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 14-Oct-2025 $15M Completed Generating Revenue
10. Seed Round 03-Aug-2022 Completed Generating Revenue
9. Grant 25-Jul-2022 Completed Generating Revenue
8. Grant 24-May-2022 Completed Generating Revenue
7. Seed Round 27-Aug-2021 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
5. Grant 15-Sep-2020 Completed Generating Revenue
4. Grant 01-Apr-2020 Completed Generating Revenue
3. Grant 01-Jan-2020 $252K Completed Generating Revenue
2. Grant 28-Mar-2019 $225K Completed Generating Revenue
To view Ascribe’s complete valuation and funding history, request access »

Ascribe Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Series A
Seed-3
Seed-2 236,797 $0.000100 $8.87 $8.87 1x $8.87 10.56%
Seed-1 56,381 $0.000100 $7.09 $7.09 1x $7.09 2.51%
To view Ascribe’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ascribe Patents

  • 54

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 34

    Pending

  • Expiring in next 12 mo

Ascribe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026180962-A1 Compositions and methods to control bacterial pathogens in monocot plants Pending 25-Feb-2025
AU-2025263433-A1 Modified ascarosides Pending 23-Apr-2024
WO-2025226798-A1 Modified ascarosides Pending 23-Apr-2024
AU-2024323445-A1 Ascaroside particulate compositions and methods for use Pending 16-Aug-2023
EP-4761739-A2 Ascaroside particulate compositions and methods for use Pending 16-Aug-2023 A01N25/12
To view Ascribe’s complete patent history, request access »

Ascribe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascribe Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Corteva Corporation Minority
ICIG Ventures Corporate Venture Capital Minority
Silver Blue. Corporation Minority
Syngenta Crop Protection (Switzerland) Corporate Venture Capital Minority
National Institutes of Health Government
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Ascribe FAQs

  • When was Ascribe founded?

    Ascribe was founded in 2017.

  • Where is Ascribe headquartered?

    Ascribe is headquartered in Ithaca, NY.

  • What is the size of Ascribe?

    Ascribe has 9 total employees.

  • What industry is Ascribe in?

    Ascribe’s primary industry is Agricultural Chemicals.

  • Is Ascribe a private or public company?

    Ascribe is a Private company.

  • What is the current valuation of Ascribe?

    The current valuation of Ascribe is .

  • What is Ascribe’s current revenue?

    The current revenue for Ascribe is .

  • How much funding has Ascribe raised over time?

    Ascribe has raised $20.7M.

  • Who are Ascribe’s investors?

    Corteva, ICIG Ventures, Silver Blue., Syngenta Crop Protection (Switzerland), and National Institutes of Health are 5 of 14 investors who have invested in Ascribe.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process